A Comprehensive Review of Occular Drug Delivery System
Mrs Shabana Perveen1, Ifra Maheen2*
Abstract
The eye is one of the most anatomically protected yet pharmaceutically challenging organs for drug delivery. Precorneal, corneal, and dynamic ocular barriers restrict the entry of therapeutic agents into ocular tissues, so that less than five percent of a topically instilled dose typically reaches the intraocular compartment. Conventional ocular dosage forms such as eye drops, although widely prescribed because of their simplicity and patient acceptability, suffer from rapid precorneal drug loss, poor bioavailability, and the need for frequent instillation, which in turn compromises patient compliance and therapeutic outcomes.
The various barriers that limit ocular drug absorption, along with drug related and patient related factors influencing bioavailability, are discussed in detail. A dedicated chapter addresses the pharmacopoeial and in house evaluation parameters used to assess the quality, safety, and performance of ocular formulations, describing the underlying principle, procedure, significance, and acceptance criteria for each test.
Keywords:
Ocular Drug Delivery; Ocular Barriers; Bioavailability; Evaluation of Ocular Formulations
![International Journal of Science, Architecture, Technology and Environment [E-ISSN: 3048-8222]](https://i0.wp.com/ijsate.com/wp-content/uploads/2026/05/LOGO-1.png?fit=723%2C680&ssl=1)